Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review.
Accorsi Buttini E, Farina M, Lorenzi L, Polverelli N, Radici V, Morello E, Colnaghi F, Almici C, Ferrari E, Bianchetti A, Leoni A, Re F, Bosio K, Bernardi S, Malagola M, Re A, Russo D. Accorsi Buttini E, et al. Among authors: radici v. Front Oncol. 2023 Jan 20;13:1036455. doi: 10.3389/fonc.2023.1036455. eCollection 2023. Front Oncol. 2023. PMID: 36741006 Free PMC article.
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol).
Malagola M, Turra A, Signorini L, Corbellini S, Polverelli N, Masina L, Del Fabro G, Lorenzotti S, Fumarola B, Farina M, Morello E, Radici V, Buttini EA, Colnaghi F, Bernardi S, Re F, Caruso A, Castelli F, Russo D. Malagola M, et al. Among authors: radici v. Front Oncol. 2022 Jun 17;12:874117. doi: 10.3389/fonc.2022.874117. eCollection 2022. Front Oncol. 2022. PMID: 35785189 Free PMC article.
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia.
Malagola M, Polverelli N, Beghin A, Bolda F, Comini M, Farina M, Morello E, Radici V, Accorsi Buttini E, Bernardi S, Re F, Leoni A, Bonometti D, Brugnoni D, Lanfranchi A, Russo D. Malagola M, et al. Among authors: radici v. Front Oncol. 2023 Mar 6;13:1133418. doi: 10.3389/fonc.2023.1133418. eCollection 2023. Front Oncol. 2023. PMID: 36950550 Free PMC article.
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.
Malagola M, Radici V, Farina M, Pellizzeri S, Spoldi F, Morello E, Polverelli N, Buttini EA, Bernardi S, Re F, Leoni A, Signorini L, Caruso A, Russo D. Malagola M, et al. Among authors: radici v. Bone Marrow Transplant. 2024 Jan;59(1):138-140. doi: 10.1038/s41409-023-02124-y. Epub 2023 Oct 19. Bone Marrow Transplant. 2024. PMID: 37857841 Free PMC article. No abstract available.
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation.
Morello E, Brambilla G, Bernardi S, Villanacci V, Carlessi M, Farina M, Radici V, Samarani E, Pellizzeri S, Polverelli N, Leoni A, Andreoli M, Arena F, Ricci C, Malagola M, Russo D. Morello E, et al. Among authors: radici v. Transpl Immunol. 2023 Dec;81:101954. doi: 10.1016/j.trim.2023.101954. Epub 2023 Nov 4. Transpl Immunol. 2023. PMID: 37931667 Free article.
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.
Malagola M, Radici V, Farina M, Pellizzeri S, Spoldi F, Morello E, Polverelli N, Buttini EA, Bernardi S, Re F, Leoni A, Signorini L, Caruso A, Russo D. Malagola M, et al. Among authors: radici v. Bone Marrow Transplant. 2024 Feb;59(2):293. doi: 10.1038/s41409-023-02158-2. Bone Marrow Transplant. 2024. PMID: 38030882 Free PMC article. No abstract available.
Inequalities in the career pathway for paediatric HSCT and cellular therapy physicians.
Gurnari C, Spadea M, Muratori R, Jimenez V, Radici V, Torrado S, Desai N, Ropero J, Muhsen IN, Ibrahimova A, Du Toit J, Hendricks CL, Gagelmann N, Horga C. Gurnari C, et al. Among authors: radici v. Lancet Haematol. 2023 Jul;10(7):e492-e494. doi: 10.1016/S2352-3026(23)00180-1. Lancet Haematol. 2023. PMID: 37414023 No abstract available.
14 results